[go: up one dir, main page]

FR3060755B1 - Methode de diagnostic d'une peau presentant des signes de secheresse - Google Patents

Methode de diagnostic d'une peau presentant des signes de secheresse Download PDF

Info

Publication number
FR3060755B1
FR3060755B1 FR1662670A FR1662670A FR3060755B1 FR 3060755 B1 FR3060755 B1 FR 3060755B1 FR 1662670 A FR1662670 A FR 1662670A FR 1662670 A FR1662670 A FR 1662670A FR 3060755 B1 FR3060755 B1 FR 3060755B1
Authority
FR
France
Prior art keywords
dryness
signs
skin
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1662670A
Other languages
English (en)
Other versions
FR3060755A1 (fr
Inventor
Sandra Kanani
Virginie Piffaut
Aude Foucher
Nukhet Cavusoglu
Mark Donovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1662670A priority Critical patent/FR3060755B1/fr
Priority to US16/466,460 priority patent/US20190353665A1/en
Priority to EP17821543.0A priority patent/EP3555619A1/fr
Priority to PCT/EP2017/082805 priority patent/WO2018109078A1/fr
Priority to JP2019532131A priority patent/JP6943960B2/ja
Publication of FR3060755A1 publication Critical patent/FR3060755A1/fr
Priority to JP2021087656A priority patent/JP2021153587A/ja
Application granted granted Critical
Publication of FR3060755B1 publication Critical patent/FR3060755B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne une méthode de diagnostic d'une peau présentant des signes de sécheresse, basée sur la mesure du niveau d'expression du gène codant la LCN1. La présente invention porte également sur une méthode de traitement cosmétique de la peau. La présente invention concerne également une méthode d'identification de composé permettant la réduction et/ou le ralentissement de la progression des signes de sécheresse d'une peau ainsi qu'un kit.
FR1662670A 2016-12-16 2016-12-16 Methode de diagnostic d'une peau presentant des signes de secheresse Active FR3060755B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1662670A FR3060755B1 (fr) 2016-12-16 2016-12-16 Methode de diagnostic d'une peau presentant des signes de secheresse
US16/466,460 US20190353665A1 (en) 2016-12-16 2017-12-14 Method for diagnosing a skin displaying signs of dryness
EP17821543.0A EP3555619A1 (fr) 2016-12-16 2017-12-14 Procédé de diagnostic d'une peau présentant des signes de sécheresse
PCT/EP2017/082805 WO2018109078A1 (fr) 2016-12-16 2017-12-14 Procédé de diagnostic d'une peau présentant des signes de sécheresse
JP2019532131A JP6943960B2 (ja) 2016-12-16 2017-12-14 乾燥の徴候を呈している皮膚を診断するための方法
JP2021087656A JP2021153587A (ja) 2016-12-16 2021-05-25 乾燥の徴候を呈している皮膚を診断するための方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1662670A FR3060755B1 (fr) 2016-12-16 2016-12-16 Methode de diagnostic d'une peau presentant des signes de secheresse
FR1662670 2016-12-16

Publications (2)

Publication Number Publication Date
FR3060755A1 FR3060755A1 (fr) 2018-06-22
FR3060755B1 true FR3060755B1 (fr) 2024-07-12

Family

ID=58228254

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1662670A Active FR3060755B1 (fr) 2016-12-16 2016-12-16 Methode de diagnostic d'une peau presentant des signes de secheresse

Country Status (5)

Country Link
US (1) US20190353665A1 (fr)
EP (1) EP3555619A1 (fr)
JP (2) JP6943960B2 (fr)
FR (1) FR3060755B1 (fr)
WO (1) WO2018109078A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2294216A4 (fr) 2008-05-14 2011-11-23 Dermtech Int Diagnostic de mélanome et de lentigo solaire par analyse d'acides nucléiques
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
US11127176B2 (en) * 2019-01-31 2021-09-21 L'oreal Systems and methods for visualizing future skin trends based on biomarker analysis
JP2022529409A (ja) * 2019-04-05 2022-06-22 ダームテック，インク． Ｕｖ損傷のモニタリングに使用するための新規な遺伝子分類子
US11741523B2 (en) 2019-07-31 2023-08-29 L'oreal Personalized skincare recommendations based on biomarker analysis
US11501356B2 (en) 2019-07-31 2022-11-15 L'oreal Systems and methods for generating personalized skincare formulations based on biomarker analysis
FR3100451B1 (fr) * 2019-09-05 2021-09-17 Oreal Méthode de diagnostic de peaux sèches

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007126391A1 (fr) * 2006-04-28 2007-11-08 Singapore Health Services Pte Ltd Recherche d'états de sécheresse des muqueuses
FR2948021A1 (fr) * 2009-07-16 2011-01-21 Oreal Utilisation cosmetique de polypeptides de type lacritine
KR100961874B1 (ko) 2010-04-05 2010-06-09 주식회사 나노엔텍 외부동력 없이 유체가 이동하는 유체분석용 칩
US9671410B2 (en) * 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
KR101507234B1 (ko) 2013-07-17 2015-03-31 로레알 생분자 추출기 및 생분자 추출방법

Also Published As

Publication number Publication date
FR3060755A1 (fr) 2018-06-22
JP2021153587A (ja) 2021-10-07
WO2018109078A1 (fr) 2018-06-21
JP6943960B2 (ja) 2021-10-06
JP2020501567A (ja) 2020-01-23
EP3555619A1 (fr) 2019-10-23
US20190353665A1 (en) 2019-11-21

Similar Documents

Publication Publication Date Title
FR3060755B1 (fr) Methode de diagnostic d'une peau presentant des signes de secheresse
GB2463401B (en) Characterizing prostate disorders by analysis of microvesicles
MX2020010947A (es) Metodos de tratamiento de enfermedad de alzheimer.
WO2016109782A3 (fr) Méthodes et compositions pour la détection de néoplasies colorectales
MX390772B (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
EP4060048A3 (fr) Procédé de diagnostic non invasif pour diagnostiquer un cancer de la vessie
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
WO2015094995A3 (fr) Biomarqueurs de signature génique de réponse tumorale à des antagonistes de pd-1
MX388989B (es) Biomarcadores basados en sangre para diagnosticar enfermedad de arteria coronaria ateroesclerótica.
SV2017005577A (es) Metodos para diagnosticar y tratar el cancer
FR3061305B1 (fr) Methode de diagnostic des qualites esthetiques de la peau
EP4242329A3 (fr) Utilisation de marqueurs comprenant de la filamine a dans le diagnostic et le traitement du cancer de la prostate
MY200300A (en) Methods for determining dpp3 and therapeutic methods
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
EP4428157A3 (fr) Utilisation de l'expression génique spécifique de cellules immunitaires pour le pronostic du cancer de la prostate et la prédiction de la réactivité à une radiothérapie
WO2015094996A3 (fr) Biomarqueurs de la signature du gène pd-l1 de la réponse tumorale aux antagonistes de pd-1
EP4424704A3 (fr) Biomarqueur multiplex destiné à être utilisé dans l'évaluation de l'état d'accumulation d'amyloïde b dans le cerveau, et procédé d'analyse pour ladite évaluation
EA201492284A1 (ru) Применение маркеров в диагностике и лечении рака предстательной железы
WO2016057702A3 (fr) Procédés de pronostic et de prévention du cancer métastatique du foie
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
AR080361A1 (es) Identificacion, evaluacion y terapia de canceres con resistencia innata o adquirida a inhibidores de quinasa del linfoma anaplasico (alk)
MX2024004195A (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto.
MX377026B (es) Biomarcadores para la progresión de enfermedades en melanoma.
CA2967867C (fr) Procedes pour la detection et le traitement d'un cancer colorectal
MX2019008005A (es) Metodos y composiciones para diagnosticar preeclampsia.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180622

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10